UBS Group »

Cytek Biosciences shares owned by UBS Group

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $201 22 9.14
2023-09-30 $3.4k 617 5.52
2023-06-30 $2.0M 233k 8.54
2023-03-31 $710k 77k 9.19
2022-12-31 $461k 45k 10.21
2022-09-30 $69k 4.0k 17.09
2022-06-30 $999 63 15.87
2021-09-30 $18k 831 21.66